Perbedaan Fore Kopi Indonesia Tbk. dan Prodia Diagnostic Line Tbk: Fore Kopi Indonesia Tbk. diperdagangkan di Rp850 (kapitalisasi pasar 6,87 T, volume 24 jam 10,5 jt), sedangkan Prodia Diagnostic Line Tbk diperdagangkan di Rp270 (kapitalisasi pasar 474,07 M, volume 24 jam 21,23 jt). Perbedaan utamanya: Fore Kopi Indonesia Tbk. jauh lebih besar — sekitar 14,5× kapitalisasi pasar Prodia Diagnostic Line Tbk, dan Prodia Diagnostic Line Tbk lebih aktif diperdagangkan (21,23 jt vs 10,5 jt). Mana yang lebih baik tergantung tujuan investasimu.
| FORE | PRDL | |
|---|---|---|
Kapitalisasi Pasar | 6,87 T | 474,07 M |
Volume | 10,5 jt | 21,23 jt |
Lot | 104,96 rb | 212,3 rb |
Perputaran | 8,53 M | 5,77 M |
Harga Rata-rata | 812,44 | 271,63 |
Nilai Transaksi | 8,53 M | 5,77 M |
Harga Ekuilibrium Indikatif | 850 | 270 |
Volume Ekuilibrium Indikatif | 5,47 rb | 2,21 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Selengkapnya di halaman FORE →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →